Amphastar Pharmaceuticals, Inc. (AMPH)
23.62
-0.20
(-0.84%)
USD |
NASDAQ |
Sep 18, 16:00
23.61
-0.01
(-0.04%)
After-Hours: 20:00
Amphastar Pharmaceuticals Total Long Term Debt (Quarterly) : 679.52M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 679.52M |
| March 31, 2026 | 676.67M |
| December 31, 2025 | 648.07M |
| September 30, 2025 | 648.95M |
| June 30, 2025 | 647.62M |
| March 31, 2025 | 644.79M |
| December 31, 2024 | 643.74M |
| September 30, 2024 | 625.64M |
| June 30, 2024 | 616.58M |
| March 31, 2024 | 623.17M |
| December 31, 2023 | 619.74M |
| September 30, 2023 | 668.84M |
| June 30, 2023 | 525.61M |
| March 31, 2023 | 99.03M |
| December 31, 2022 | 99.58M |
| September 30, 2022 | 100.06M |
| June 30, 2022 | 100.61M |
| March 31, 2022 | 102.00M |
| December 31, 2021 | 101.68M |
| September 30, 2021 | 103.27M |
| June 30, 2021 | 63.09M |
| March 31, 2021 | 60.97M |
| December 31, 2020 | 63.91M |
| September 30, 2020 | 62.60M |
| June 30, 2020 | 61.23M |
| Date | Value |
|---|---|
| March 31, 2020 | 63.10M |
| December 31, 2019 | 63.45M |
| September 30, 2019 | 61.99M |
| June 30, 2019 | 64.49M |
| March 31, 2019 | 59.73M |
| December 31, 2018 | 50.21M |
| September 30, 2018 | 51.20M |
| June 30, 2018 | 52.59M |
| March 31, 2018 | 45.77M |
| December 31, 2017 | 47.16M |
| September 30, 2017 | 48.44M |
| June 30, 2017 | 46.31M |
| March 31, 2017 | 36.41M |
| December 31, 2016 | 37.72M |
| September 30, 2016 | 42.70M |
| June 30, 2016 | 42.65M |
| March 31, 2016 | 40.27M |
| December 31, 2015 | 41.10M |
| September 30, 2015 | 46.12M |
| June 30, 2015 | 47.43M |
| March 31, 2015 | 48.42M |
| December 31, 2014 | 43.70M |
| September 30, 2014 | 51.35M |
| June 30, 2014 | 53.52M |
| March 31, 2014 | 41.50M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Viatris, Inc. | 13.51B |
| Johnson & Johnson | 37.34B |
| Eli Lilly & Co. | 49.62B |
| Merck & Co., Inc. | 51.08B |
| Pfizer Inc. | 63.10B |